Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula ...

Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula business. A deal for nutrition and Mead Johnson could potentially materialise ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

On Wednesday, Reckitt said its operating profit fell 4.2 per cent to £2.43billion last year, while revenue fell 3 per cent to ...

Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...